Sep 22 | Mar 22 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 723.35M | $ 909.15M | $ 393.06M | $ 573.58M | $ 490.22M |
Total Assets | $ 8.44B | $ 8.14B | $ 7.46B | $ 7.33B | $ 7.43B |
Total Debt | $ 332.00M | $ 387.25M | $ 494.33M | $ 599.47M | $ 683.83M |
Net Debt | $ -391.35M | $ -521.91M | $ 101.27M | $ 25.89M | $ 193.61M |
Total Liabilities | $ 3.65B | $ 3.63B | $ 3.45B | $ 3.21B | $ 3.46B |
Stockholders Equity | $ 4.79B | $ 4.51B | $ 4.00B | $ 4.11B | $ 3.96B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |